Slate Path Capital LP Bausch Health Companies Inc. Transaction History

Slate Path Capital LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$13.31 - $20.51 $56.5 Million - $87.1 Million	-4,245,000 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$12.98 - $30.25 $17.3 Million - $40.4 Million	-1,334,948 Reduced 23.92%	4,245,000 $65.8 Million
Q4 2019 Feb 14, 2020	BUY	$18.89 - $31.89 $105 Million - $178 Million	5,579,948 New	5,579,948 $167 Million

254

254M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.69B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Slate Path Capital LP, based on Form 13F filings with the SEC.

Stay updated on Slate Path Capital LP with notifications on news.